Addex Therapeutics Ltd ADR (ADXN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Sales | 425 | 743 | 1,090 | 933 | 1,996 |
| Gross Profit | 425 | 743 | 1,090 | 933 | 1,996 |
| Operating Expenses | 5,067 | 4,639 | 6,037 | 4,413 | 4,166 |
| Operating Income | -4,642 | -3,896 | -4,947 | -3,480 | -2,170 |
| Interest Expense | 10 | 11 | 25 | 23 | 261 |
| Other Income | -158 | -13 | -176 | 585 | 2 |
| Pre-tax Income | -4,810 | -3,920 | -5,148 | -2,918 | -2,428 |
| Net Income Continuous | -4,810 | -3,920 | -5,148 | -2,918 | -2,428 |
| Net Income | $-4,810 | $-3,920 | $-5,148 | $-2,918 | $-2,428 |
| EPS Basic Total Ops | -15.65 | -14.38 | -18.44 | -10.61 | -10.98 |
| EPS Basic Continuous Ops | -16.70 | -13.79 | -18.14 | -10.45 | -10.86 |
| EPS Diluted Total Ops | -15.65 | -14.38 | -18.44 | -10.61 | -10.98 |
| EPS Diluted Continuous Ops | -16.70 | -13.79 | -18.14 | -10.45 | -10.86 |
| EBITDA(a) | $-4,550 | $-3,802 | $-4,851 | $-3,382 | $-2,088 |